Skip to content
Back to Investors
B

Braavos

Venture Capital

Portfolio

4

companies

Investment by month

By category

  • Uncategorised£44.6M
  • BioTech£41.7M
  • Quantum Computing£29.0M
  • CleanTech£20.8M

By location

  • London£70.7M
  • Oxford£65.4M

Portfolio companies

CHARM Therapeutics

CHARM Therapeutics

Discovering small molecule therapeutics through proprietary 3D deep-learning protein-ligand technology.

O

OXCCU

Converting waste gases directly into sustainable aviation fuel with a patented iron-based catalyst.

PQShield

PQShield

PQShield builds quantum-resistant cryptographic solutions for the global technology supply chain.

WB

Wild Bioscience

Wild Bioscience develops climate-resilient crop varieties using evolutionary biology and artificial intelligence.


Recent investments

Series A
$60.0M

The round was led by the Ellison Institute of Technology and will fund research and commercial expansion.

"Advancing agriculture has limitless potential to help people and the planet. So to achieve meaningful, scalable impact, we need the right investors who are truly aligned with that big vision. I’m deeply grateful to EIT and to our current investors for sharing our excitement about what we’ve accomplished so far, and for their united support as we embark on this ambitious growth journey together."
— Ross Hendron, Co-Founder and CEO
Series B
£29.0M

Addition led the Series B round with participation from Chevron Technology Ventures, Legal & General, Braavos Capital, and Oxford Science Enterprises.

"As we approach the culmination of the NIST project, we expect newly-ratified standards to help drive rapid adoption of PQC across the technology supply chain. Led by an industry-leading team with decades of experience, PQShield has quickly established itself as a leading authority in post-quantum cryptography for hardware and software. We are excited to see the business continue to build on its existing commercial success and further enhance its efforts in protecting our digital future."
— Todd Arfman